Skip to main content
NCBI home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1994 Sep;23:S4–10.

The normal Langerhans cell and the LCH cell.

T Chu 1, R Jaffe 1
PMCID: PMC2149705  PMID: 7521202

Abstract

The epidermal Langerhans cell is the bone marrow-derived dendritic, antigen-presenting cell of the skin. It is characterised by a unique intracytoplasmic organelle--the Birbeck granule--and constitutively expresses class II MHC molecules and the CD1a glycoprotein. The Langerhans cell represents one of the most potent antigen-presenting cells of the body, and fulfils an important role in detecting foreign antigen entering the body through the skin and in immune surveillance. The distribution of Langerhans cells is restricted to the skin, lymph nodes, bronchial mucosa and thymus. The discovery by Nézelof in 1973 that the lesional cells in the disease then called 'Histiocytosis X' contained Birbeck granules established the close relationship between the Langerhans cell and this disease and led ultimately to the adoption of the name Langerhans cell histiocytosis to replace the older term. The LCH cell expresses the phenotype of a Langerhans cell apparently 'fixed' at an early stage of cell activation. The LCH cell is, however, functionally defective in antigen presentation, and the tissue distribution of the disease--affecting bone, skin, lymph node, lung, liver, spleen, CNS, gastro-intestinal tract and bone marrow--is quite different from the normal distribution of the Langerhans cell. Studies are now under way throughout the world to investigate the relationship between the normal Langerhans cell and the LCH cell. Specifically we need to identify whether the LCH cell is a cell arrested at a specific time in normal Langerhans cell ontogeny or if it represents a response to a biological insult to the mature Langerhans cell or its precursors.

Full text

PDF
S4

Images in this article

S6Figure 3
on p.S6

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austyn J. M. Lymphoid dendritic cells. Immunology. 1987 Oct;62(2):161–170. [PMC free article] [PubMed] [Google Scholar]
  2. BREATHNACH A. S., BIRBECK M. S., EVERALL J. D. Observations bearing on the relationship between langerhans cells and melanocytes. Ann N Y Acad Sci. 1963 Feb 15;100:223–238. doi: 10.1111/j.1749-6632.1963.tb57122.x. [DOI] [PubMed] [Google Scholar]
  3. BREATHNACH A. S. OBSERVATIONS ON CYTOPLASMIC ORGANELLES IN LANGERHANS CELLS OF HUMAN EPIDERMIS. J Anat. 1964 Apr;98:265–270. [PMC free article] [PubMed] [Google Scholar]
  4. Balk S. P., Burke S., Polischuk J. E., Frantz M. E., Yang L., Porcelli S., Colgan S. P., Blumberg R. S. Beta 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science. 1994 Jul 8;265(5169):259–262. doi: 10.1126/science.7517575. [DOI] [PubMed] [Google Scholar]
  5. Berman B., France D. S. Histochemical analysis of Langerhans' cells. Am J Dermatopathol. 1979 Fall;1(3):215–221. doi: 10.1097/00000372-197900130-00003. [DOI] [PubMed] [Google Scholar]
  6. Bilsland C. A., Milstein C. The identification of the beta 2-microglobulin binding antigen encoded by the human CD1D gene. Eur J Immunol. 1991 Jan;21(1):71–78. doi: 10.1002/eji.1830210112. [DOI] [PubMed] [Google Scholar]
  7. Cattoretti G., Pileri S., Parravicini C., Becker M. H., Poggi S., Bifulco C., Key G., D'Amato L., Sabattini E., Feudale E. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol. 1993 Oct;171(2):83–98. doi: 10.1002/path.1711710205. [DOI] [PubMed] [Google Scholar]
  8. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature. 1992 Nov 19;360(6401):258–261. doi: 10.1038/360258a0. [DOI] [PubMed] [Google Scholar]
  9. Chu A., Eisinger M., Lee J. S., Takezaki S., Kung P. C., Edelson R. L. Immunoelectron microscopic identification of Langerhans cells using a new antigenic marker. J Invest Dermatol. 1982 Feb;78(2):177–180. doi: 10.1111/1523-1747.ep12506352. [DOI] [PubMed] [Google Scholar]
  10. Cocchia D., Michetti F., Donato R. Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin. Nature. 1981 Nov 5;294(5836):85–87. doi: 10.1038/294085a0. [DOI] [PubMed] [Google Scholar]
  11. Czernielewski J. M., Demarchez M. Further evidence for the self-reproducing capacity of Langerhans cells in human skin. J Invest Dermatol. 1987 Jan;88(1):17–20. doi: 10.1111/1523-1747.ep12464659. [DOI] [PubMed] [Google Scholar]
  12. Favara B. E., Jaffe R. Pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1987 Mar;1(1):75–97. [PubMed] [Google Scholar]
  13. Fithian E., Kung P., Goldstein G., Rubenfeld M., Fenoglio C., Edelson R. Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2541–2544. doi: 10.1073/pnas.78.4.2541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Freeman G. J., Freedman A. S., Segil J. M., Lee G., Whitman J. F., Nadler L. M. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol. 1989 Oct 15;143(8):2714–2722. [PubMed] [Google Scholar]
  15. Hage C., Willman C. L., Favara B. E., Isaacson P. G. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction. Hum Pathol. 1993 Aug;24(8):840–845. doi: 10.1016/0046-8177(93)90133-2. [DOI] [PubMed] [Google Scholar]
  16. Hanau D., Fabre M., Schmitt D. A., Garaud J. C., Pauly G., Cazenave J. P. Appearance of Birbeck granule-like structures in anti-T6 antibody-treated human epidermal Langerhans cells. J Invest Dermatol. 1988 Mar;90(3):298–304. doi: 10.1111/1523-1747.ep12456083. [DOI] [PubMed] [Google Scholar]
  17. Hanau D., Fabre M., Schmitt D. A., Stampf J. L., Garaud J. C., Bieber T., Grosshans E., Benezra C., Cazenave J. P. Human epidermal Langerhans cells internalize by receptor-mediated endocytosis T6 (CD1 "NA1/34") surface antigen. Birbeck granules are involved in the intracellular traffic of the T6 antigen. J Invest Dermatol. 1987 Aug;89(2):172–177. doi: 10.1111/1523-1747.ep12470555. [DOI] [PubMed] [Google Scholar]
  18. Kanitakis J., Fantini F., Pincelli C., Hermier C., Schmitt D., Thivolet J. Neuron-specific enolase is a marker of cutaneous Langerhans' cell histiocytosis ("X")-a comparative study with S100 protein. Anticancer Res. 1991 Mar-Apr;11(2):635–639. [PubMed] [Google Scholar]
  19. Kashihara M., Ueda M., Horiguchi Y., Furukawa F., Hanaoka M., Imamura S. A monoclonal antibody specifically reactive to human Langerhans cells. J Invest Dermatol. 1986 Nov;87(5):602–607. doi: 10.1111/1523-1747.ep12455849. [DOI] [PubMed] [Google Scholar]
  20. Kasinrerk W., Baumruker T., Majdic O., Knapp W., Stockinger H. CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. J Immunol. 1993 Jan 15;150(2):579–584. [PubMed] [Google Scholar]
  21. Katz S. I., Tamaki K., Sachs D. H. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature. 1979 Nov 15;282(5736):324–326. doi: 10.1038/282324a0. [DOI] [PubMed] [Google Scholar]
  22. Knowles R. W., Bodmer W. F. A monoclonal antibody recognizing a human thymus leukemia-like antigen associated with beta 2-microglobulin. Eur J Immunol. 1982 Aug;12(8):676–681. doi: 10.1002/eji.1830120810. [DOI] [PubMed] [Google Scholar]
  23. Krenács L., Tiszalvicz L., Krenács T., Boumsell L. Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. J Pathol. 1993 Oct;171(2):99–104. doi: 10.1002/path.1711710206. [DOI] [PubMed] [Google Scholar]
  24. Martin L. H., Calabi F., Milstein C. Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9154–9158. doi: 10.1073/pnas.83.23.9154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McLelland J., Chu A. C. Comparison of peanut agglutinin and S100 stains in the paraffin tissue diagnosis of Langerhans cell histiocytosis. Br J Dermatol. 1988 Oct;119(4):513–519. doi: 10.1111/j.1365-2133.1988.tb03255.x. [DOI] [PubMed] [Google Scholar]
  26. Mierau G. W., Favara B. E. S-100 protein immunohistochemistry and electron microscopy in the diagnosis of Langerhans cell proliferative disorders: a comparative assessment. Ultrastruct Pathol. 1986;10(4):303–309. doi: 10.3109/01913128609064194. [DOI] [PubMed] [Google Scholar]
  27. Morris J., Alaibac M., Jia M. H., Chu T. Purification of functional active epidermal Langerhans cells: a simple and efficient new technique. J Invest Dermatol. 1992 Aug;99(2):237–240. doi: 10.1111/1523-1747.ep12650459. [DOI] [PubMed] [Google Scholar]
  28. Nezelof C., Basset F., Rousseau M. F. Histiocytosis X histogenetic arguments for a Langerhans cell origin. Biomedicine. 1973 Sep;18(5):365–371. [PubMed] [Google Scholar]
  29. Porcelli S., Brenner M. B., Greenstein J. L., Balk S. P., Terhorst C., Bleicher P. A. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature. 1989 Oct 5;341(6241):447–450. doi: 10.1038/341447a0. [DOI] [PubMed] [Google Scholar]
  30. Reid C. D., Fryer P. R., Clifford C., Kirk A., Tikerpae J., Knight S. C. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood. 1990 Sep 15;76(6):1139–1149. [PubMed] [Google Scholar]
  31. Reinherz E. L., Kung P. C., Goldstein G., Levey R. H., Schlossman S. F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588–1592. doi: 10.1073/pnas.77.3.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Reis e Sousa C., Stahl P. D., Austyn J. M. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med. 1993 Aug 1;178(2):509–519. doi: 10.1084/jem.178.2.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rowden G., Lewis M. G., Sullivan A. K. Ia antigen expression on human epidermal Langerhans cells. Nature. 1977 Jul 21;268(5617):247–248. doi: 10.1038/268247a0. [DOI] [PubMed] [Google Scholar]
  34. Santiago-Schwarz F., Belilos E., Diamond B., Carsons S. E. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol. 1992 Sep;52(3):274–281. [PubMed] [Google Scholar]
  35. Schuler G., Steinman R. M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med. 1985 Mar 1;161(3):526–546. doi: 10.1084/jem.161.3.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Silberberg-Sinakin I., Gigli I., Baer R. L., Thorbecke G. J. Langerhans cells: role in contact hypersensitivity and relationship to lymphoid dendritic cells and to macrophages. Immunol Rev. 1980;53:203–232. doi: 10.1111/j.1600-065x.1980.tb01045.x. [DOI] [PubMed] [Google Scholar]
  37. Steiner G., Tschachler E., Tani M., Malek T. R., Shevach E. M., Holter W., Knapp W., Wolff K., Stingl G. Interleukin 2 receptors on cultured murine epidermal Langerhans cells. J Immunol. 1986 Jul 1;137(1):155–159. [PubMed] [Google Scholar]
  38. Stössel H., Koch F., Kämpgen E., Stöger P., Lenz A., Heufler C., Romani N., Schuler G. Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med. 1990 Nov 1;172(5):1471–1482. doi: 10.1084/jem.172.5.1471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Symington F. W., Brady W., Linsley P. S. Expression and function of B7 on human epidermal Langerhans cells. J Immunol. 1993 Feb 15;150(4):1286–1295. [PubMed] [Google Scholar]
  40. Tschachler E., Groh V., Popovic M., Mann D. L., Konrad K., Safai B., Eron L., diMarzo Veronese F., Wolff K., Stingl G. Epidermal Langerhans cells--a target for HTLV-III/LAV infection. J Invest Dermatol. 1987 Feb;88(2):233–237. doi: 10.1111/1523-1747.ep12525402. [DOI] [PubMed] [Google Scholar]
  41. Willman C. L., Busque L., Griffith B. B., Favara B. E., McClain K. L., Duncan M. H., Gilliland D. G. Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease. N Engl J Med. 1994 Jul 21;331(3):154–160. doi: 10.1056/NEJM199407213310303. [DOI] [PubMed] [Google Scholar]
  42. Wood G. S., Warner N. L., Warnke R. A. Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. J Immunol. 1983 Jul;131(1):212–216. [PubMed] [Google Scholar]
  43. Yu R. C., Chu C., Buluwela L., Chu A. C. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet. 1994 Mar 26;343(8900):767–768. doi: 10.1016/s0140-6736(94)91842-2. [DOI] [PubMed] [Google Scholar]
  44. Yu R. C., Morris J. F., Pritchard J., Chu T. C. Defective alloantigen-presenting capacity of 'Langerhans cell histiocytosis cells'. Arch Dis Child. 1992 Nov;67(11):1370–1372. doi: 10.1136/adc.67.11.1370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Zelickson A. S. Granule formation in the Langerhans cell. J Invest Dermatol. 1966 Nov;47(5):498–502. [PubMed] [Google Scholar]
  46. de Fraissinette A., Schmitt D., Dezutter-Dambuyant C., Guyotat D., Zabot M. T., Thivolet J. Culture of putative Langerhans cell bone marrow precursors: characterization of their phenotype. Exp Hematol. 1988 Oct;16(9):764–768. [PubMed] [Google Scholar]
  47. van Agthoven A., Terhorst C. Further biochemical characterization of the human thymocyte differentiation antigen T6. J Immunol. 1982 Jan;128(1):426–432. [PubMed] [Google Scholar]
  48. van de Rijn M., Lerch P. G., Knowles R. W., Terhorst C. The thymic differentiation markers T6 and M241 are two unusual MHC class I antigens. J Immunol. 1983 Aug;131(2):851–855. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES